Efficacy, safety, and prognostic factors of PD-1 inhibitors combined with lenvatinib and Gemox chemotherapy as first-line treatment in advanced intrahepatic cholangiocarcinoma: a multicenter real-world study.
作者:
主题词
人类(Humans);回顾性研究(Retrospective Studies);预后(Prognosis);胆管上皮癌(Cholangiocarcinoma);胆管肿瘤(Bile Duct Neoplasms);胆管, 肝内(Bile Ducts, Intrahepatic)
DOI
10.1007/s00262-023-03466-8
PMID
37247023
发布时间
2024-09-26
- 浏览0

Cancer immunology, immunotherapy
2949-2960页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文